v3.26.1
Financing Arrangements - Narrative (Details)
€ in Billions
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 29, 2025
USD ($)
Jan. 31, 2026
USD ($)
Jul. 31, 2026
USD ($)
Jul. 25, 2025
USD ($)
Apr. 24, 2026
USD ($)
Sep. 29, 2025
EUR (€)
tranche
Schedule of Debt [Line Items]            
Current debt obligations     $ 2,536,000,000   $ 1,788,000,000  
Interest expense on outstanding borrowings     235,000,000 $ 217,000,000    
Senior Notes            
Schedule of Debt [Line Items]            
Principal value     27,400,000,000   28,100,000,000  
Estimated fair value     $ 24,400,000,000   25,300,000,000  
Credit Facility | Line of Credit            
Schedule of Debt [Line Items]            
Term of debt instrument     5 years      
Line of credit, maximum capacity     $ 3,500,000,000      
Line of credit, amount outstanding     0   0  
MiniMed Revolving Credit Facility | Line of Credit | Revolving Credit Facility            
Schedule of Debt [Line Items]            
Term of debt instrument   5 years        
Line of credit, maximum capacity   $ 500,000,000        
Line of credit, amount outstanding     0      
Medtronic Luxco Senior Notes | Senior Notes            
Schedule of Debt [Line Items]            
Principal value | €           € 1.5
Proceeds from (repayments of) debt $ 1,700,000,000          
Medtronic Luxco Senior Notes | Senior Notes | Medtronic Luxco            
Schedule of Debt [Line Items]            
Number of tranches | tranche           2
Commercial Paper            
Schedule of Debt [Line Items]            
Commercial paper, maximum borrowing amount     3,500,000,000      
Current debt obligations     $ 450,000,000   $ 0  
Weighted average interest rate     3.81%   4.17%